Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-Resistant aHUS
Study Identifier:
C08-002A
ClinicalTrials.gov Identifier:
EudraCT Identifier:
N/A
Sponsor:
Alexion Pharmaceuticals, Inc.
Study Contact Information:
N/A
Study Complete
Study Details
Medical Condition
- Unmapped
Study Drug
- Drug: Eculizumab
Date
May 2009 - Sep 2010
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 18+ years
Requirements Information
Sex
Female & Male
Age
18+ years
Study Details
Medical Condition
- Unmapped
Study Drug
- Drug: Eculizumab
Date
May 2009 - Sep 2010
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 18+ years years
Requirements Information
Protocol Summary
The purpose of this study is to determine whether eculizumab is safe and effective in the treatment of adult patients with plasma therapy-resistant Atypical Hemolytic-Uremic Syndrome (aHUS).
Trial Locations
Location
Status
Location
Atlanta, Georgia, United States, 30322
Status
N/A
Location
Fort Wayne, Indiana, United States, 46804
Status
N/A
Location
New York, New York, United States, 10032
Status
N/A
Location
New York, New York, United States, 10065
Status
N/A
Location
Grapevine, Texas, United States, 76051
Status
N/A
Location
Houston, Texas, United States, 77030
Status
N/A